Singh G
From the Department of Dermato- Venereology and Hair Transplantation, Mohan Dai Oswal Cancer Treatment and Research Foundation, Ludhiana-141 009, Punjab, India, .
Indian J Dermatol Venereol Leprol. 1998 Jan-Feb;64(1):23-4.
Forty patients suffering from androgenetic alopecia were given 3 to 4 sittings of hair transplantation at an interval of 4 to 6 weeks each. Only patients of type III, type III(vertex) and type IV baldness were operated. Twenty patients, six of type III, six of type III(vertex) and eight of type IV baldness were advised to use minoxidil 2% locally at the recipient area in the dose of 1 ml applied twice daily. Twenty patients of similar types of baldness were advised to just shampoo their hair daily without using topical minoxidil. Percentage of response was compared between the two groups. Minoxidil did not play any role in the percentage of hair survival before and after transplantation in androgenetic alopecia. However in 60percent grafts of patients who had used topical minoxidil, there was no initial postoperative hair shedding.
40名雄激素性脱发患者接受了3至4次植发治疗,每次间隔4至6周。仅对III型、III型(头顶)和IV型秃发患者进行手术。20名患者,其中6名III型、6名III型(头顶)和8名IV型秃发患者被建议在受区局部使用2%米诺地尔,剂量为1毫升,每日涂抹两次。另外20名相同类型秃发的患者被建议每天仅用洗发水洗头,不使用外用米诺地尔。比较了两组的反应百分比。米诺地尔在雄激素性脱发患者移植前后的毛发存活率百分比方面没有任何作用。然而,在使用外用米诺地尔的患者中,60%的移植毛囊术后初期没有脱发。